Previous Close | 231.77 |
Open | 234.15 |
Bid | 92.60 x 900 |
Ask | 259.99 x 1100 |
Day's Range | 226.28 - 236.11 |
52 Week Range | 217.20 - 460.21 |
Volume | |
Avg. Volume | 565,191 |
Market Cap | 11.74B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | 30.13 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
WILMINGTON, Mass., May 04, 2022--Charles River Laboratories Announces First-Quarter 2022 Results
WILMINGTON, Mass. & BOSTON, April 27, 2022--Charles River and Valo have launched Logica, an AI-powered drug solution that translates biological insights into optimized preclinical assets.
WILMINGTON, Mass., April 13, 2022--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2022 financial results on Wednesday, May 4th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 9:30 a.m. ET.